IntelGenx Corp. a drug delivery company focused on the development and manufacturing of pharmaceutical films, is executing a plan focused on near-term revenue generation. The core of IntelGenx’s strategy to drive additional revenue in the short-term is centered on three key objectives: • Continue to Expand our Core CDMO Business: Earlier in May, IntelGenx received an amended Drug Establishment License from Health Canada, allowing the company to further expand its CDMO business to inc...